Safety and cost savings of reducing adult dengue hospitalization in a tertiary care hospital in Singapore

Linda K Lee, Arul Earnest, Luis R Carrasco, Tun L Thein, Victor C Gan, Vernon J Lee, David C Lye, Yee-Sin Leo, Linda K Lee, Arul Earnest, Luis R Carrasco, Tun L Thein, Victor C Gan, Vernon J Lee, David C Lye, Yee-Sin Leo

Abstract

Background: Previously, most dengue cases in Singapore were hospitalized despite low incidence of dengue hemorrhagic fever (DHF) or death. To minimize hospitalization, the Communicable Disease Centre at Tan Tock Seng Hospital (TTSH) in Singapore implemented new admission criteria which included clinical, laboratory, and DHF predictive parameters in 2007.

Method: All laboratory-confirmed dengue patients seen at TTSH during 2006-2008 were retrospectively reviewed for clinical data. Disease outcome and clinical parameters were compared over the 3 years.

Results: There was a 33.0% mean decrease in inpatients after the new criteria were implemented compared with the period before (p < 0.001). The proportion of inpatients with DHF increased significantly from 31.7% in 2006 to 34.4% in 2008 (p = 0.008); 68 DHF cases were managed safely on an outpatient basis after compared with none before implementation. DHF inpatients had more serious signs such as clinical fluid accumulation (15.5% vs 2.9% of outpatients), while most DHF outpatients had hypoproteinemia (92.7% vs 81.3% of inpatients). The eight intensive care unit admissions and five deaths during this time period all occurred among inpatients. The new criteria resulted in a median cost saving of US$1.4 million to patients in 2008.

Conclusion: The new dengue admission criteria were effective in sustainably reducing length of hospitalization, yielding considerable cost savings. A minority of DHF patients with mild symptoms recovered uneventfully through outpatient management.

Figures

Figure 1.
Figure 1.
Monthly proportion of dengue patients admitted to Tan Tock Seng Hospital, Singapore, January 2006–December 2008.

References

    1. WHO. Geneva: World Health Organization; 1997. Dengue hemorrhagic fever: diagnosis, treatment, prevention and control.
    1. WHO. Geneva: World Health Organization; 2009. Dengue: guidelines for diagnosis, treatment, prevention and control.
    1. Ooi EE, Goh KT, Gubler DJ. Dengue prevention and 35 years of vector control in Singapore. Emerg Infect Dis. 2006;12:887–93.
    1. MOH. Singapore: Ministry of Health; 2005. Communicable diseases in Singapore 2004.
    1. MOH. Singapore: Ministry of Health; 2006. Communicable diseases in Singapore 2005.
    1. MOH. Singapore: Ministry of Health; 2007. Communicable diseases in Singapore 2006.
    1. MOH. Singapore: Ministry of Health; 2008. Communicable diseases in Singapore 2007.
    1. MOH. Singapore: Ministry of Health; 2009. Communicable diseases in Singapore 2008.
    1. MOH. Singapore: Ministry of Health; 2002. Communicable diseases in Singapore 2001.
    1. MOH. Singapore: Ministry of Health; 2003. Communicable diseases in Singapore 2002.
    1. MOH. Singapore: Ministry of Health; 2004. Communicable diseases in Singapore 2003.
    1. Chin CK. Outpatient management of dengue infection in the University Hospital, Kuala Lumpur. Malays J Pathol. 1993;15:21–3.
    1. Ingram PR, Mahadevan M, Fisher DA. Dengue management: practical and safe hospital-based outpatient care. Trans R Soc Trop Med Hyg. 2009;103:203–5.
    1. MOH. Singapore: Ministry of Health; 2005. Report of the Expert Panel on Dengue.
    1. Barkham TM, Chung YK, Tang KF, et al. The performance of RT-PCR compared with a rapid serological assay for acute dengue fever in a diagnostic laboratory. Trans R Soc Trop Med Hyg. 2006;100:142–8.
    1. Cuzzubbo AJ, Endy TP, Nisalak A, et al. Use of recombinant envelope proteins for serological diagnosis of dengue virus infection in an immunochromatographic assay. Clin Diagn Lab Immunol. 2001;8:1150–5.
    1. Lee VJ, Lye DC, Sun Y, et al. Predictive value of simple clinical and laboratory variables for dengue hemorrhagic fever in adults. J Clin Virol. 2008;42:34–9.
    1. Lee VJ, Lye DC, Sun Y, et al. Decision tree algorithm in deciding hospitalization for adult patients with dengue haemorrhagic fever in Singapore. Trop Med Int Health. 2009;14:1154–9.
    1. Helfenstein U. Box–Jenkins modelling in medical research. Stat Methods Med Res. 1996;5:3–22.
    1. Thein TL, Leo YS, Lee VJ, et al. Validation of probability equation and decision tree in predicting subsequent dengue hemorrhagic fever in adult dengue inpatients in Singapore. Am J Trop Med Hyg. 2011;85:942–5.
    1. Carrasco LR, Lee LK, Lee VJ, et al. Economic impact of dengue illness and the cost-effectiveness of future vaccination programs in Singapore. PLoS Negl Trop Dis. 2011;5:e1426.
    1. Lee KS, Lai YL, Lo S, et al. Dengue virus surveillance for early warning, Singapore. Emerg Infect Dis. 2010;16:847–9.
    1. Guzman MG, Kouri G. Dengue: an update. Lancet Infect Dis. 2002;2:33–42.
    1. Wilder-Smith A, Yoksan S, Earnest A, et al. Serological evidence for the co-circulation of multiple dengue virus serotypes in Singapore. Epidemiol Infect. 2005;133:667–71.
    1. MOH. Singapore: Ministry of Health; 2011. Healthcare financing, hospital bill size, Singapore Ministry of Health, dengue age <60.
    1. LTA. Singapore: Land Transport Authority; 2010. Singapore Land Transport Statistics in Brief 2010.

Source: PubMed

3
Iratkozz fel